<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="https://blogs.mercola.com:443/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /><title>FDA Approves Teva’s Generic of Mylan’s EpiPen</title><link>https://blogs.mercola.com:443/sites/vitalvotes/archive/2018/08/19/fda-approves-tevas-generic-of-mylan_1920_s-epipen.aspx</link><description>The EpiPen &amp;mdash; which injects a dose of epinephrine to someone in a life-threatening allergy attack &amp;mdash; has a competitor. Drug giant Mylan has held the purse strings to the drug for years, and raised the prices for it to astronomical levels to</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Debug Build: 31106.3070)</generator></channel></rss>